Working to facilitate rapid translation of scientific discoveries into therapeutics

Peter Kennedy

A. Koulaouzidis

Prof. Peter Kennedy

CBE, MD, PhD, DSc, M.Phil, M.Litt, FRCPath, FRCP, FMedSci, FRSE

Prof. Kennedy holds the Burton Chair of Neurology at the University of Glasgow since 1987. He is also Consultant Neurologist at the Institute of Neurological Sciences in the Southern General Hospital, Glasgow and head of the division of clinical neurosciences. He is a world leader in the study of African Sleeping Sickness. His work involved frequent research visits to the African field, and, using a well-established mouse model, his group has developed a novel oral form of the toxic intravenous drug melarsoprol for late-stage (CNS) disease. He has published over 200 scientific articles.

Prof. Kennedy is a fellow of both the Royal Society of Edinburgh (FRSE) and the Academy of Medical Sciences (FMedSci). He is also a fellow of the Royal College of Physicians, the Royal College of Pathologists and the Association of Physicians. In 2010, he was appointed a Commander of the Order of the British Empire (CBE) by The Queen for ‘services to clinical science’. He is the recipient of numerous awards for his research, most recently receiving the Sir James Black Medal (senior prize in the biomedical sciences) of the Royal Society of Edinburgh for his “outstanding contributions to tropical medicine though his pioneering work in human African trypanosomiasis and Neurovirology”

2013-2021©European Society for Translational Medicine (EUSTM)